Skip to main content
ILLUMINA, INC. logo

ILLUMINA, INC. — Investor Relations & Filings

Ticker · ILMN ISIN · US4523271090 LEI · SQ95QG8SR5Q56LSNF682 US Manufacturing
Open in API
Filings indexed 2,572 across all filing types
Latest filing 2021-02-05 Regulatory Filings
Country US United States of America
Listing US ILMN

About ILLUMINA, INC.

https://www.illumina.com

Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company is a provider of DNA sequencing and array-based technologies. Its portfolio includes next-generation sequencing (NGS) platforms, microarrays, library preparation kits, and bioinformatics software. These products and services are utilized by researchers and clinicians for applications in life science research, translational and consumer genomics, molecular diagnostics, oncology, and reproductive health. The company's solutions are designed to advance genomic discoveries and enable precision medicine by providing tools for DNA, RNA, and protein analysis.

Recent filings

Filing Released Lang Actions
425 Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes an amendment to a merger agreement between Illumina, Inc. and GRAIL, Inc., including details about tax withholdings and merger consideration. It also references the filing of a Form S-4 registration statement related to the merger transaction. The document is not a full annual or quarterly report, nor is it an earnings release or management discussion. It is a regulatory filing announcing a material definitive agreement amendment related to a merger. The document length is about 11,370 characters, which is typical for an 8-K filing with detailed disclosures. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it does not fit into more specific categories like M&A Activity (TAR) or Merger & Acquisition (MA) which are typically reserved for merger proposals, tender offers, or proxy statements, whereas this is an amendment announcement within an 8-K form.
2021-02-05 English
PRIMARY DOCUMENT
Director's Dealing
2021-02-03 English
PRIMARY DOCUMENT
Director's Dealing
2021-02-03 English
PRIMARY DOCUMENT
Director's Dealing
2021-02-03 English
PRIMARY DOCUMENT
Director's Dealing
2021-02-03 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-01-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.